Related Experiment Video
Updated: Jul 8, 2025

Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication
Published on: December 11, 2013
Hypertension Management in Peripheral Artery Disease: A Mini Review.
A Kharawala1,2, S Nagraj2,3, S Pargaonkar1,2
1Department of Medicine, New York City Health+Hospitals/Jacobi, Bronx, NY, USA.
Managing hypertension in peripheral artery disease (PAD) requires careful blood pressure control to avoid complications. Current guidelines suggest ACE inhibitors or ARBs, but more research is needed for optimal treatment targets in PAD patients.
Area of Science:
- Cardiovascular Medicine
- Vascular Health
- Hypertension Management
Background:
- Peripheral artery disease (PAD) impacts over 230 million adults globally.
- Hypertension is a significant risk factor for PAD development.
- Patients with both hypertension and PAD often receive suboptimal treatment.
Purpose of the Study:
- To review current evidence on hypertension management in PAD patients.
- To discuss guideline-directed therapies for this population.
- To identify areas requiring further investigation.
Main Methods:
- Review of existing scientific literature and clinical guidelines.
- Analysis of studies examining blood pressure levels and outcomes in PAD.
- Synthesis of recommendations from major cardiology societies.
Main Results:
- Both high and low blood pressure levels are linked to adverse outcomes in PAD.
- Cautious blood pressure management is recommended to prevent hypotension.
- ACE inhibitors (ACEI) or angiotensin receptor blockers (ARB) are favored initial antihypertensive choices.
Conclusions:
- Current data on blood pressure targets in PAD are limited, often from subgroup analyses.
- Further large-scale randomized trials are essential for definitive hypertension management strategies in PAD.
- Optimizing hypertension treatment in PAD patients remains an area for future research.
More Related Videos
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Antihypertensive Drugs: Vasodilators

